Showing results (261-270 of 391) with videos related to

Sort By:
Pageof 40
The Journal of Rheumatology|April 2, 2021
Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical PracticeEva Galíndez-Agirregoikoa, Diana Prieto-Peña, José Luis Martín-Varillas, et al.
Arthritis Research & Therapy|June 5, 2024
Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literatureJavier Loricera, Toluwalase Tofade, Diana Prieto-Peña, et al.
Nefrologia|January 24, 2025
Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitisEnrique Morales, Iñigo Rúa-Figueroa, José Luis Callejas Rubio, et al.
NEJM Evidence|June 3, 2026
Secukinumab for Giant Cell ArteritisJohn H Stone, Nils Venhoff, Frank Buttgereit, et al.
Journal of Clinical Medicine|December 23, 2020
Endothelial Progenitor Cells as a Potential Biomarker in Interstitial Lung Disease Associated with Rheumatoid ArthritisVerónica Pulito-Cueto, Sara Remuzgo-Martínez, Fernanda Genre, et al.
International Journal of Molecular Sciences|January 21, 2023
Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune DiseasesVerónica Pulito-Cueto, Fernanda Genre, Raquel López-Mejías, et al.
Clinical and Experimental Rheumatology|April 8, 2016
The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label studyMontserrat Santos-Gómez, Vanesa Calvo-Río, Ricardo Blanco, et al.
The Journal of Dermatological Treatment|May 11, 2017
Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasisFernanda Genre, Susana Armesto, Alfonso Corrales, et al.
Seminars in Arthritis and Rheumatism|February 19, 2021
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patientsMónica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro, et al.
Pageof 40